Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 4
1986 1
1987 4
1988 7
1989 2
1990 9
1991 6
1992 11
1993 7
1994 7
1995 5
1996 6
1997 3
1998 5
1999 9
2000 3
2001 10
2002 12
2003 7
2004 22
2005 16
2006 22
2007 25
2008 32
2009 40
2010 50
2011 53
2012 34
2013 51
2014 47
2015 40
2016 49
2017 41
2018 43
2019 50
2020 64
2021 69
2022 64
2023 39

Text availability

Article attribute

Article type

Publication date

Search Results

818 results

Results by year

Filters applied: . Clear all
Page 1
Update of EULAR recommendations for the treatment of systemic sclerosis.
Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U; EUSTAR Coauthors. Kowal-Bielecka O, et al. Among authors: matucci cerinic m. Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9. Ann Rheum Dis. 2017. PMID: 27941129 Free article.
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Khanna D, Lin CJF, Furst DE, Goldin J, Kim G, Kuwana M, Allanore Y, Matucci-Cerinic M, Distler O, Shima Y, van Laar JM, Spotswood H, Wagner B, Siegel J, Jahreis A, Denton CP; focuSSced investigators. Khanna D, et al. Among authors: matucci cerinic m. Lancet Respir Med. 2020 Oct;8(10):963-974. doi: 10.1016/S2213-2600(20)30318-0. Epub 2020 Aug 28. Lancet Respir Med. 2020. PMID: 32866440 Clinical Trial.
Very early systemic sclerosis.
Bellando-Randone S, Matucci-Cerinic M. Bellando-Randone S, et al. Among authors: matucci cerinic m. Best Pract Res Clin Rheumatol. 2019 Aug;33(4):101428. doi: 10.1016/j.berh.2019.101428. Epub 2019 Sep 3. Best Pract Res Clin Rheumatol. 2019. PMID: 31810547 Review.
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE. van den Hoogen F, et al. Among authors: matucci cerinic m. Ann Rheum Dis. 2013 Nov;72(11):1747-55. doi: 10.1136/annrheumdis-2013-204424. Ann Rheum Dis. 2013. PMID: 24092682 Free article.
Undifferentiated connective tissue disease: state of the art on clinical practice guidelines.
Antunes M, Scirè CA, Talarico R, Alexander T, Avcin T, Belocchi C, Doria A, Franceschini F, Galetti I, Govoni M, Hachulla E, Launay D, Lepri G, Macieira C, Matucci-Cerinic M, Montecucco CM, Moraes-Fontes MF, Mouthon L, Paolino S, Ramoni V, Tani C, Tas SW, Tincani A, Van Vollenhoven R, Zen M, Fonseca J, Bombardieri S, Fonseca JE, Schneider M, Smith V, Cutolo M, Mosca M, Beretta L. Antunes M, et al. Among authors: matucci cerinic m. RMD Open. 2019 Feb 26;4(Suppl 1):e000786. doi: 10.1136/rmdopen-2018-000786. eCollection 2018. RMD Open. 2019. PMID: 30886731 Free PMC article. Review.
Systemic Sclerosis Association with Malignancy.
Lepri G, Catalano M, Bellando-Randone S, Pillozzi S, Giommoni E, Giorgione R, Botteri C, Matucci-Cerinic M, Antonuzzo L, Guiducci S. Lepri G, et al. Among authors: matucci cerinic m. Clin Rev Allergy Immunol. 2022 Dec;63(3):398-416. doi: 10.1007/s12016-022-08930-4. Epub 2022 Sep 19. Clin Rev Allergy Immunol. 2022. PMID: 36121543 Free PMC article. Review.
Systemic sclerosis in the time of COVID-19.
Hoffmann-Vold AM, Distler O, Bruni C, Denton CP, de Vries-Bouwstra J, Matucci Cerinic M, Vonk MC, Gabrielli A. Hoffmann-Vold AM, et al. Among authors: matucci cerinic m. Lancet Rheumatol. 2022 Aug;4(8):e566-e575. doi: 10.1016/S2665-9913(22)00130-8. Epub 2022 Jul 21. Lancet Rheumatol. 2022. PMID: 35891634 Free PMC article. Review.
The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases.
Wang Y, Chen S, Zheng S, Lin J, Hu S, Zhuang J, Lin Q, Xie X, Zheng K, Zhang W, Du G, Zhang G, Hoffmann-Vold AM, Matucci-Cerinic M, Furst DE. Wang Y, et al. Among authors: matucci cerinic m. Arthritis Res Ther. 2021 Aug 14;23(1):212. doi: 10.1186/s13075-021-02586-9. Arthritis Res Ther. 2021. PMID: 34391465 Free PMC article. Review.
818 results